Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Reva Efe"'
Publikováno v:
International Journal of Breast Cancer, Vol 2022 (2022)
Objectives. Patients with early-stage HR+/HER2- N0 breast cancer may receive adjuvant chemotherapy in combination with surgery. However, chemotherapy does not always lead to improved survival and incurs high healthcare costs and increased adverse eve
Externí odkaz:
https://doaj.org/article/d8d1f84ff5734916988b7d1fbc5a758a
Autor:
Reva Efe, Sylvia Vijgen
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S61-S61
IntroductionGuidance on appropriate methods to obtain a comparator arm for the cost-effectiveness analysis of tumor-agnostic drugs is needed. In recent years, multiple tumor-agnostic drugs have been submitted to health technology assessment (HTA) bod